Skin Care News

Rapid itch reduction was positively correlated with treatment response among patients taking dupilumab for bullous pemphigoid, according to a study.

Optical coherence tomography may be able to guide treatment for port wine birthmarks that show wide variability in vessel density and size, but improvements are needed, according to a study.

Medicaid coverage for tretinoin is often granted for acne vulgaris but not pigmentary disorders, which disproportionately affect patients with skin of color, according to a study. Healio spoke with a dermatologist about these findings.

Omalizumab is effective and safe for the treatment of chronic urticaria, demonstrating high discontinuation due to well-controlled disease, according to a study.

In a new study published in the Journal of Drugs in Dermatology, researchers discussed how and why dermatologists have a significant role to play in the diagnosing and addressing of body dysmorphic disorder.

Healio has compiled July’s most-read news in dermatology.

In this video, Hansa Bhargava, MD, and Victoria Barbosa, MD, MPH, MBA, FAAD, discuss the impact of UV rays on aging and the risk for skin cancer, as well as ways to protect your skin from the sun.

Enrollment in the phase 3 VALOR study evaluating brepocitinib for the treatment of dermatomyositis has been completed, Priovant Therapeutics announced in a press release.

A new imaging device effectively monitored skin texture changes in patients with skin of color with atopic dermatitis and xerosis following a prebiotic skincare regimen, according to a study.

Topically applied nanoparticle-encapsulated cannabidiol cream helped prevent and repair damage to the skin from ultraviolet A radiation, according to a first-of-its-kind study.